• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/12/21 4:21:17 PM ET
    $LOAC
    Business Services
    Finance
    Get the next $LOAC alert in real time by email
    SC 13G/A 1 brhc10020121_sc13ga.htm SC 13G


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549

     

     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*
     
    LONGEVITY ACQUISITION CORPORATION
     (Name of Issuer)
     
    Ordinary shares, no par value
     (Title of Class of Securities)
     
    G56372132
     (CUSIP Number)
     
    December 31, 2020
     (Date of Event which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    [    ] Rule 13d-1(b)
     
    [ X ] Rule 13d-1(c)
     
    [    ] Rule 13d-1(d)
     
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     

    Continued on following pages
    Page 1 of 11 Pages
    Exhibit Index: Page 10

    CUSIP No. G56372132
     
    Page 2 of 11 Pages

    1
    NAMES OF REPORTING PERSONS
     
     
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     
     
     BASSO SPAC FUND LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0.0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO
     
     
     
     


    CUSIP No. G56372132
     
    Page 3 of 11 Pages
     
    1
    NAMES OF REPORTING PERSONS
     
     
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     
     
     BASSO MANAGEMENT, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0.0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO
     
     
     
     


    CUSIP No. G56372132
     
    Page 4 of 11 Pages
     
    1
    NAMES OF REPORTING PERSONS
     
     
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     
     
     BASSO CAPITAL MANAGEMENT, L.P.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0.0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     IA, PN
     
     
     
     


    CUSIP No. G56372132
     
    Page 5 of 11 Pages
     
    1
    NAMES OF REPORTING PERSONS
     
     
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     
     
     BASSO GP, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0.0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO, HC
     
     
     
     


    CUSIP No. G56372132
     
    Page 6 of 11 Pages
     
    1
    NAMES OF REPORTING PERSONS
     
     
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     
     
     HOWARD I. FISCHER
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     United States
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     0
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0.0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     IN, HC
     
     
     
     



     
    Page 7 of 11 Pages
     
    Item 1(a).
    Name of Issuer:

    Longevity Activity Corporation (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    Yongda International Tower No. 2277, Longyang Road, Pudong District, Shanghai, People’s Republic of China

    Item 2(a).
    Name of Person Filing

    This Statement is filed on behalf of the following persons (collectively, the “Reporting Persons”):


    i)
    Basso SPAC Fund LLC (“Basso SPAC”);

    ii)
    Basso Management, LLC (“Basso Management”);

    iii)
    Basso Capital Management, L.P. (“BCM”);

    iv)
    Basso GP, LLC (“Basso GP”); and

    v)
    Howard I. Fischer (“Mr. Fischer”).

    This Statement relates to Shares (as defined herein) directly beneficially owned by Basso SPAC. Basso Management is the manager of Basso SPAC. BCM serves as the investment manager of Basso SPAC. Basso GP is the general partner of BCM. Mr. Fischer is the principal portfolio manager for Basso SPAC, the Chief Executive Officer and a founding partner of BCM, and a member of each of Basso Management and Basso GP. Accordingly, each of Basso Management, BCM, Basso GP and Mr. Fischer may be deemed to indirectly beneficially own the Shares reported herein.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons is 1266 East Main Street, Fourth Floor, Stamford, Connecticut 06902.

    Item 2(c).
    Citizenship:

    Each of Basso SPAC, Basso Management, and Basso GP is a Delaware limited liability company. BCM is a Delaware limited partnership. Mr. Fischer is a citizen of the United States.

    Item 2(d).
    Title of Class of Securities:
     
    Ordinary shares, no par value (the “Shares”)

    Item 2(e).
    CUSIP Number:

    G56372132

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.

    Item 4.
    Ownership:

    Item 4(a)
    Amount Beneficially Owned:

    As of December 31, 2020, each of the Reporting Persons may be deemed the beneficial owner of 0 Shares.



     
    Page 8 of 11 Pages
     
    Item 4(b)
    Percent of Class:

    As of December 31, 2020, each of the Reporting Persons may be deemed the beneficial owner of approximately 0.00% of Shares outstanding.

    Item 4(c)
    Number of Shares as to which such person has:
     
    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    0
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    0
     
    Item 5.
    Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following ☒.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    This Item 6 is not applicable.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     


     
    Page 9 of 11 Pages
     
    SIGNATURE
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
      BASSO SPAC FUND LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Authorized Signatory  
           

      BASSO MANAGEMENT, LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Member  
           

      BASSO CAPITAL MANAGEMENT, L.P.  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Chief Executive Officer & Founding Partner  
           
     
      BASSO GP, LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Member  
           
     
      HOWARD I. FISCHER  

    /s/ Howard I. Fischer  
       
     
       
     
           
     
     
     February 12, 2021
     


     


     
    Page 10 of 11 Pages
     
     
    EXHIBIT INDEX
     
    Ex.
     
    Page No.
         
    A
    Joint Filing Agreement 11

     

     






     
    Page 11 of 11 Pages
     

    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the ordinary shares of Longevity Acquisition Corporation dated as of February 12, 2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
     

      BASSO SPAC FUND LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Authorized Signatory  
           
     
      BASSO MANAGEMENT, LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Member  
           

      BASSO CAPITAL MANAGEMENT, L.P.  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Chief Executive Officer & Founding Partner  
           
     
      BASSO GP, LLC  
           

    By:
    /s/ Howard I. Fischer  
        Name: Howard I. Fischer  
        Title:   Member  
           
     
      HOWARD I. FISCHER  

    /s/ Howard I. Fischer  
       
     
       
     
           
     

     
     February 12, 2021
     
     

    Get the next $LOAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LOAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LOAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    4D pharma Announces Completion of Merger With Longevity Acquisition Corporation

    LEEDS, England--(BUSINESS WIRE)--4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome - today announced completion of its merger (“the Merger”) with Longevity Acquisition Corporation ("Longevity")(Nasdaq: LOAC). 4D pharma American Depositary Shares (“ADSs”) are expected to begin trading today on the Nasdaq Global Market under the ticker symbol ‘LBPS.’ Warrants of Longevity assumed by 4D pharma in the Merger are currently expected to begin trading on Nasdaq under the ticker symbol ‘LBPSW’ tomorrow, Tuesday, March 23, 2021. Lo

    3/22/21 3:00:00 AM ET
    $LOAC
    Business Services
    Finance

    Longevity Acquisition Corporation Announces Results of Special Meeting of Shareholders

    NEW YORK, March 18, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today the results of its special meeting of shareholders, which was held on March 17, 2021. At the special meeting, shareholders of the Company approved the merger, including a certain agreement and plan of merger, dated as of October 21, 2020, by and among 4d pharma plc, the Company and Dolphin Merger Sub Limited, and the related agreements and transactions contemplated thereby. About LOAC LOAC is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of

    3/18/21 8:00:00 AM ET
    $LOAC
    Business Services
    Finance

    4D Pharma to Present at Upcoming Investor Conferences in March

    LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: Chardan's Virtual 3rd Annual Microbiome Medicines Summit: Monday March 8, 2021 at 11:45 am ET (16:45 GMT). H.C. Wainwright Global Life Sciences Conference: Available on-demand starting Tuesday, March 9, 2021 at 7:00 am ET (12:00 GMT). Oppenheimer’s 31st Annual Healthcare Conference: Tuesday, March 16, 2021 at 8:40 am ET (12:40 GMT). About 4D pharma Founded in February 2014, 4D pharma is a w

    3/3/21 7:00:00 AM ET
    $LOAC
    Business Services
    Finance

    $LOAC
    SEC Filings

    View All

    SEC Form EFFECT filed by Longevity Acquisition Corporation

    EFFECT - Longevity Acquisition Corp (0001743858) (Filer)

    4/7/21 12:15:42 AM ET
    $LOAC
    Business Services
    Finance

    SEC Form 15-15D filed by Longevity Acquisition Corporation

    15-15D - Longevity Acquisition Corp (0001743858) (Filer)

    4/1/21 1:05:04 PM ET
    $LOAC
    Business Services
    Finance

    SEC Form POS AM filed by Longevity Acquisition Corporation

    POS AM - Longevity Acquisition Corp (0001743858) (Filer)

    3/31/21 1:21:13 PM ET
    $LOAC
    Business Services
    Finance

    $LOAC
    Leadership Updates

    Live Leadership Updates

    View All

    4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team

    LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the Company’s management team, bringing over 30 years of experience in finance, including three previous positions as Chief Financial Officer of publicly traded life sciences companies. “John will be an important addition to 4D pharma’s management team at such a pivotal time, as the company prepares to close our SPAC merger and begin trading on NASDAQ. His deep experience and financial expert

    3/1/21 7:00:00 AM ET
    $LOAC
    Business Services
    Finance

    $LOAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)

    2/16/21 3:16:03 PM ET
    $LOAC
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)

    2/16/21 7:36:20 AM ET
    $LOAC
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Longevity Acquisition Corp (0001743858) (Subject)

    2/12/21 4:21:17 PM ET
    $LOAC
    Business Services
    Finance